Iovance Biotherapeutics (IOVA) Revenue & Revenue Breakdown
Iovance Biotherapeutics Revenue Highlights
Latest Revenue (Y)
$1.19M
Latest Revenue (Q)
$31.11M
Main Geography (Y)
Non-US
Iovance Biotherapeutics Revenue by Period
Iovance Biotherapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.19M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | - |
Iovance Biotherapeutics generated $1.19M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Iovance Biotherapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $31.11M | 4250.49% |
| 2024-03-31 | $715.00K | 48.34% |
| 2023-12-31 | $482.00K | 2.77% |
| 2023-09-30 | $469.00K | 97.06% |
| 2023-06-30 | $238.00K | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | - |
Iovance Biotherapeutics generated $31.11M in revenue during Q2 2024, up 4250.49% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Iovance Biotherapeutics Revenue Breakdown
Iovance Biotherapeutics Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 23 | Jun 23 |
|---|---|---|
| Product | $500.00K | $200.00K |
Iovance Biotherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Product (100.00%).
Iovance Biotherapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 |
|---|---|
| Non-US | $1.20M |
| UNITED STATES | - |
Iovance Biotherapeutics's latest annual revenue breakdown by geography, as of Dec 23: Non-US (100.00%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 |
|---|---|---|---|---|
| Non-US | $700.00K | $500.00K | $500.00K | $200.00K |
| UNITED STATES | - | - | - | - |
Iovance Biotherapeutics's latest quarterly revenue breakdown by geography, as of Mar 24: Non-US (100.00%).
Iovance Biotherapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SRPT | Sarepta Therapeutics | $1.24B | $413.46M |
| PTCT | PTC Therapeutics | $937.82M | $186.70M |
| APLS | Apellis Pharmaceuticals | $366.28M | $179.14M |
| CVAC | CureVac | $52.70M | $12.37M |
| KRYS | Krystal Biotech | $50.70M | $70.28M |
| IOVA | Iovance Biotherapeutics | $1.19M | $31.11M |
| CWBR | CohBar | - | - |
| MDGL | Madrigal Pharmaceuticals | - | - |
| OCEA | Ocean Biomedical | - | - |
| HEPA | Hepion Pharmaceuticals | - | - |
IOVA Revenue FAQ
What is Iovance Biotherapeutics’s yearly revenue?
Iovance Biotherapeutics's yearly revenue for 2023 was $1.19M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. IOVA's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Iovance Biotherapeutics’s quarterly revenue?
Iovance Biotherapeutics's quarterly revenue for Q2 2024 was $31.11M, a 4250.49% increase from the previous quarter (Q1 2024), and a 12969.75% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $715K, a 48.34% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). IOVA's quarterly revenue for Q4 2023 was $482K, a 2.77% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Iovance Biotherapeutics’s revenue growth rate?
Iovance Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.